Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine.
<p>Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine.</p>
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , , , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1852022889379790848 |
|---|---|
| author | Md. Nahian (20571297) |
| author2 | Md. Rasel Khan (20571300) Fabiha Rahman (20691385) Hossain Mohammed Reza (20691388) Imren Bayil (18887023) Tanjum Ahmed Nodee (20691391) Tabassum Basher (20691394) Mostafizur Rahaman Sany (20691397) Rabeya Najnin Munmun (20691400) S. M. Ariful Habib (20691403) Lincon Mazumder (15455463) Mrityunjoy Acharjee (3761959) |
| author2_role | author author author author author author author author author author author |
| author_facet | Md. Nahian (20571297) Md. Rasel Khan (20571300) Fabiha Rahman (20691385) Hossain Mohammed Reza (20691388) Imren Bayil (18887023) Tanjum Ahmed Nodee (20691391) Tabassum Basher (20691394) Mostafizur Rahaman Sany (20691397) Rabeya Najnin Munmun (20691400) S. M. Ariful Habib (20691403) Lincon Mazumder (15455463) Mrityunjoy Acharjee (3761959) |
| author_role | author |
| dc.creator.none.fl_str_mv | Md. Nahian (20571297) Md. Rasel Khan (20571300) Fabiha Rahman (20691385) Hossain Mohammed Reza (20691388) Imren Bayil (18887023) Tanjum Ahmed Nodee (20691391) Tabassum Basher (20691394) Mostafizur Rahaman Sany (20691397) Rabeya Najnin Munmun (20691400) S. M. Ariful Habib (20691403) Lincon Mazumder (15455463) Mrityunjoy Acharjee (3761959) |
| dc.date.none.fl_str_mv | 2025-02-07T18:29:28Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0318750.t001 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Predicted_LBL_CTL_and_HTL_epitopes_from_BabA_CagA_and_VacA_proteins_for_the_development_of_multi-epitope_vaccine_/28371259 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Microbiology Biotechnology Immunology Cancer Infectious Diseases Space Science Biological Sciences not elsewhere classified Information Systems not elsewhere classified secondary mrna structure optimized restriction sites current drug treatments control infections caused computational approaches offer epitope subunit vaccine chosen vaccine constructs licensed vaccines available epitope subunit vaccines proposed vaccine candidates helicobacter pylori </ molecular docking simulations vaccine candidates molecular docking pylori </ safe vaccines immune simulations silico </ h </ − 20 viable strategy viable alternative vaca ). structural flexibility strongly immunogenic scale production potent b population coverage persistently infects performed using peptic ulcers negative bacterium mediated immunity laboratory validation increased risk immunoinformatic strategy human stomach gastric cancer favored regions extremophilic characteristics evaluated based designing antigenic codon adaptation bacterium make analyses suggest |
| dc.title.none.fl_str_mv | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine. |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_2b248b4bc079e28b5bfbfa5be1f08058 |
| identifier_str_mv | 10.1371/journal.pone.0318750.t001 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/28371259 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine.Md. Nahian (20571297)Md. Rasel Khan (20571300)Fabiha Rahman (20691385)Hossain Mohammed Reza (20691388)Imren Bayil (18887023)Tanjum Ahmed Nodee (20691391)Tabassum Basher (20691394)Mostafizur Rahaman Sany (20691397)Rabeya Najnin Munmun (20691400)S. M. Ariful Habib (20691403)Lincon Mazumder (15455463)Mrityunjoy Acharjee (3761959)MicrobiologyBiotechnologyImmunologyCancerInfectious DiseasesSpace ScienceBiological Sciences not elsewhere classifiedInformation Systems not elsewhere classifiedsecondary mrna structureoptimized restriction sitescurrent drug treatmentscontrol infections causedcomputational approaches offerepitope subunit vaccinechosen vaccine constructslicensed vaccines availableepitope subunit vaccinesproposed vaccine candidateshelicobacter pylori </molecular docking simulationsvaccine candidatesmolecular dockingpylori </safe vaccinesimmune simulationssilico </h </− 20viable strategyviable alternativevaca ).structural flexibilitystrongly immunogenicscale productionpotent bpopulation coveragepersistently infectsperformed usingpeptic ulcersnegative bacteriummediated immunitylaboratory validationincreased riskimmunoinformatic strategyhuman stomachgastric cancerfavored regionsextremophilic characteristicsevaluated baseddesigning antigeniccodon adaptationbacterium makeanalyses suggest<p>Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine.</p>2025-02-07T18:29:28ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0318750.t001https://figshare.com/articles/dataset/Predicted_LBL_CTL_and_HTL_epitopes_from_BabA_CagA_and_VacA_proteins_for_the_development_of_multi-epitope_vaccine_/28371259CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/283712592025-02-07T18:29:28Z |
| spellingShingle | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine. Md. Nahian (20571297) Microbiology Biotechnology Immunology Cancer Infectious Diseases Space Science Biological Sciences not elsewhere classified Information Systems not elsewhere classified secondary mrna structure optimized restriction sites current drug treatments control infections caused computational approaches offer epitope subunit vaccine chosen vaccine constructs licensed vaccines available epitope subunit vaccines proposed vaccine candidates helicobacter pylori </ molecular docking simulations vaccine candidates molecular docking pylori </ safe vaccines immune simulations silico </ h </ − 20 viable strategy viable alternative vaca ). structural flexibility strongly immunogenic scale production potent b population coverage persistently infects performed using peptic ulcers negative bacterium mediated immunity laboratory validation increased risk immunoinformatic strategy human stomach gastric cancer favored regions extremophilic characteristics evaluated based designing antigenic codon adaptation bacterium make analyses suggest |
| status_str | publishedVersion |
| title | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine. |
| title_full | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine. |
| title_fullStr | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine. |
| title_full_unstemmed | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine. |
| title_short | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine. |
| title_sort | Predicted LBL, CTL, and HTL epitopes from BabA, CagA, and VacA proteins for the development of multi-epitope vaccine. |
| topic | Microbiology Biotechnology Immunology Cancer Infectious Diseases Space Science Biological Sciences not elsewhere classified Information Systems not elsewhere classified secondary mrna structure optimized restriction sites current drug treatments control infections caused computational approaches offer epitope subunit vaccine chosen vaccine constructs licensed vaccines available epitope subunit vaccines proposed vaccine candidates helicobacter pylori </ molecular docking simulations vaccine candidates molecular docking pylori </ safe vaccines immune simulations silico </ h </ − 20 viable strategy viable alternative vaca ). structural flexibility strongly immunogenic scale production potent b population coverage persistently infects performed using peptic ulcers negative bacterium mediated immunity laboratory validation increased risk immunoinformatic strategy human stomach gastric cancer favored regions extremophilic characteristics evaluated based designing antigenic codon adaptation bacterium make analyses suggest |